The Charges for Esrd Treatment of Diabetics Dean
نویسندگان
چکیده
~-To evaluate the differential charges for treatmg end-stage renal disease (ESRD) associated with diabetes mellitus. Medicare billmg data are analyzed. The charges of 244 patients in the Michigan Kidney Registry Identified as havmg (ESRD) from diabetes are compared with charges of 902 nondiabetic patients. Average annual charges for ESRD treatment for diabetics are S29,671 (k 27.662) which are $4695 (+ 1344) higher than charges for nondiabetics. The majorit) of the difTerence (84.3%) is attributable to higher inpatient hospital charges. Most of the remainder (14.5%) is attributable to higher physician and medlcal supply charges. Charges for treatment of diabetics are higher on all modalities of treatment, but differences are not significant among modalities. Charges Diabetes End-stage renal disease
منابع مشابه
The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland--an analysis of the RENAAL study.
BACKGROUND The prevalence and incidence of diabetic nephropathy with endstage renal disease (ESRD) have increased globally over recent decades. Diabetic nephropathy with ESRD for type 2 diabetes mellitus (DM) now has to be recognized as a growing public health problem. Several studies have found that angiotensin-II receptor antagonists have a renoprotective effect in type 2 diabetics with diabe...
متن کاملDeveloping an Expert System for Diabetics Treatment Advices
Today, expert systems are widely applied in medicine for prognosis, diagnosis, checkup, and treatment of various kinds of diseases. A comprehensive system for the checkup and treatment of different types of diabetes is still lacking. This paper reports development of such a system, its validation, and its utility in facilitating medical decision-making and supporting self-care.
متن کاملIndicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
Diabetics with end-stage renal disease (ESRD) exhibit abnormal life span of erythrocytes, and thus, HbAlc is not necessarily a good indicator for blood glucose control. The present study was conducted to reaffirm this point and determine whether glycated albumin (GA) can be used instead of HbAlc. The following three groups of patients with diabetes served as subjects: 49 predialysis patients wi...
متن کاملChoice of renal replacement therapy in patients with diabetic end stage renal disease.
Diabetic nephropathy is becoming the leading cause of end-stage renal disease (ESRD) worldwide. Although the prognosis of patients with diabetes and ESRD receiving Renal Replacement Therapy (RRT) has improved greatly, the presence of pre-existing cardiovascular disease means that the survival and medical rehabilitation of diabetics continue to be inferior to that of non-diabetics. RRT should be...
متن کاملاثر همودیالیز بر فعالیت آنزیم پاراکسوناز و ظرفیت کلی آنتی اکسیدانها دربیماران مبتلا به نارسایی مرحله انتهایی کلیه
Background : Paraoxonase (PON) is an esterase with antioxidant effects, which is in close association with High Density Lipid-C, (HDL-C). Investigators have shown that the reduction of PON in patients with end-stage renal disease (ESRD) predisposes them to premature atherosclerosis and coronary artery disease. The present study was conducted to determine the impact of hemodialysis on the activi...
متن کامل